BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16153617)

  • 41. A structural interpretation of voltage-gated potassium channel inactivation.
    Kurata HT; Fedida D
    Prog Biophys Mol Biol; 2006 Oct; 92(2):185-208. PubMed ID: 16316679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Layer-specific properties of the persistent sodium current in sensorimotor cortex.
    Aracri P; Colombo E; Mantegazza M; Scalmani P; Curia G; Avanzini G; Franceschetti S
    J Neurophysiol; 2006 Jun; 95(6):3460-8. PubMed ID: 16467432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Kv1.2 potassium channel: the position of an N-glycan on the extracellular linkers affects its protein expression and function.
    Zhu J; Recio-Pinto E; Hartwig T; Sellers W; Yan J; Thornhill WB
    Brain Res; 2009 Jan; 1251():16-29. PubMed ID: 19056359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concatemers of brain Kv1 channel alpha subunits that give similar K+ currents yield pharmacologically distinguishable heteromers.
    Sokolov MV; Shamotienko O; Dhochartaigh SN; Sack JT; Dolly JO
    Neuropharmacology; 2007 Aug; 53(2):272-82. PubMed ID: 17637465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Manipulation of the potassium channel Kv1.1 and its effect on neuronal excitability in rat sensory neurons.
    Chi XX; Nicol GD
    J Neurophysiol; 2007 Nov; 98(5):2683-92. PubMed ID: 17855588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast inactivation properties of the human potassium channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.
    Imbrici P; D'Adamo MC; Kullmann DM; Pessia M
    Eur J Neurosci; 2006 Dec; 24(11):3073-83. PubMed ID: 17156368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generalized epilepsy with febrile seizures plus-associated sodium channel beta1 subunit mutations severely reduce beta subunit-mediated modulation of sodium channel function.
    Xu R; Thomas EA; Gazina EV; Richards KL; Quick M; Wallace RH; Harkin LA; Heron SE; Berkovic SF; Scheffer IE; Mulley JC; Petrou S
    Neuroscience; 2007 Aug; 148(1):164-74. PubMed ID: 17629415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.
    Shamgar L; Ma L; Schmitt N; Haitin Y; Peretz A; Wiener R; Hirsch J; Pongs O; Attali B
    Circ Res; 2006 Apr; 98(8):1055-63. PubMed ID: 16556865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.
    Jeong I; Choi BH; Yoon SH; Hahn SJ
    Biochem Pharmacol; 2012 Feb; 83(4):497-505. PubMed ID: 22146582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels.
    Grant AO; John JE; Nesterenko VV; Starmer CF; Moorman JR
    Mol Pharmacol; 1996 Dec; 50(6):1643-50. PubMed ID: 8967988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A truncated Kv1.1 protein in the brain of the megencephaly mouse: expression and interaction.
    Persson AS; Klement G; Almgren M; Sahlholm K; Nilsson J; Petersson S; Arhem P; Schalling M; Lavebratt C
    BMC Neurosci; 2005 Nov; 6():65. PubMed ID: 16305740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
    Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-glycans modulate K(v)1.5 gating but have no effect on K(v)1.4 gating.
    Schwetz TA; Norring SA; Bennett ES
    Biochim Biophys Acta; 2010 Mar; 1798(3):367-75. PubMed ID: 19961828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
    Lagrutta A; Wang J; Fermini B; Salata JJ
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Separation of P/C- and U-type inactivation pathways in Kv1.5 potassium channels.
    Kurata HT; Doerksen KW; Eldstrom JR; Rezazadeh S; Fedida D
    J Physiol; 2005 Oct; 568(Pt 1):31-46. PubMed ID: 16020465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrophysiologic characterization of a novel hERG channel activator.
    Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
    Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Constitutive CaMKII activity regulates Na+ channel in rat ventricular myocytes.
    Yoon JY; Ho WK; Kim ST; Cho H
    J Mol Cell Cardiol; 2009 Oct; 47(4):475-84. PubMed ID: 19591836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pore structure influences gating properties of the T-type Ca2+ channel alpha1G.
    Talavera K; Janssens A; Klugbauer N; Droogmans G; Nilius B
    J Gen Physiol; 2003 Jun; 121(6):529-40. PubMed ID: 12743166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Four and a half LIM protein 1: a partner for KCNA5 in human atrium.
    Yang Z; Browning CF; Hallaq H; Yermalitskaya L; Esker J; Hall MR; Link AJ; Ham AJ; McGrath MJ; Mitchell CA; Murray KT
    Cardiovasc Res; 2008 Jun; 78(3):449-57. PubMed ID: 18281375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional coupling of intracellular calcium and inactivation of voltage-gated Kv1.1/Kvbeta1.1 A-type K+ channels.
    Jow F; Zhang ZH; Kopsco DC; Carroll KC; Wang K
    Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15535-40. PubMed ID: 15486093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.